CGON
Cg Oncology Inc
NASDAQ · Biotechnology
$50.36
+1.16 (+2.36%)
Performance
1D
—
1W
-7.32%
1M
-6.25%
3M
+29.66%
6M
+90.11%
1Y
+78.14%
YTD
+20.51%
Open$50.93
Previous Close$49.20
Day High$51.50
Day Low$49.71
52W High$57.88
52W Low$14.80
Volume841.7K
Avg Volume840.9K
Market Cap4.06B
P/E Ratio—
EPS$-2.03
SectorBiotechnology
Volume Analysis
1.00x average volume
Technical Indicators
SMA 50
$46.22
Above
SMA 200
$34.96
Above
RSI (14)
38.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-28.6% upside
Current
$50.36
$50.36
Target
$35.94
$35.94
$23.54
$35.94 avg
$41.91
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 1.47M | 3.06M | 1.55B |
| Net Income | -113,634,452 | -213,464,844 | -216,062,695 |
| Profit Margin | -7,729.5% | -7,343.0% | -13.9% |
| EBITDA | -147,957,913 | -293,383,463 | -300,127,009 |
| Free Cash Flow | — | — | -249,842,018 |
| Rev Growth | -52.1% | -52.1% | +6.3% |
| Debt/Equity | — | — | 0.59 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |